Literature DB >> 15527088

Developing a brain tumor center.

Mark L Rosenblum1, Tom Mikkelsen.   

Abstract

The development of a multidisciplinary brain tumor center requires many steps, from selection of leaders to garnering institutional support, growing the clinical neuro-oncology business, and building multidisciplinary involvement especially with the tumor board. Key clinicians and researchers need to be recruited to develop the academic enterprise, and acquiring external endorsement and philanthropy support can be critical factors in maintaining institutional support and in meeting special needs of the center. The process of managing money, space and support personnel, and the maintenance of the overall program are important as well. Our views on building a brain tumor center reflect our specific situation in developing and growing the Hermelin Brain Tumor Center at Henry Ford Hospital in Detroit and hence might not be precisely applicable to the development of centers elsewhere.

Entities:  

Mesh:

Year:  2004        PMID: 15527088     DOI: 10.1023/b:neon.0000041879.30683.a4

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  3 in total

1.  Quality improvement in neurology: Neuro-Oncology Quality Measurement Set.

Authors:  Justin T Jordan; Amy E Sanders; Terri Armstrong; Tony Asher; Amy Bennett; Erin Dunbar; Nimish Mohile; P Leia Nghiemphu; Timothy R Smith; Douglas E Ney
Journal:  Neuro Oncol       Date:  2018-03-27       Impact factor: 12.300

Review 2.  Multidisciplinary pediatric brain tumor clinics: the key to successful treatment?

Authors:  Mohamed S Abdel-Baki; Emily Hanzlik; Mark W Kieran
Journal:  CNS Oncol       Date:  2015

Review 3.  A clinical care pathway to improve the acute care of patients with glioma.

Authors:  Natalie B V Riblet; Evelyn M Schlosser; Jennifer A Snide; Lara Ronan; Katherine Thorley; Melissa Davis; Jennifer Hong; Linda P Mason; Tobi J Cooney; Lanelle Jalowiec; Nancy L Kennedy; Sabrina Richie; David Nalepinski; Camilo E Fadul
Journal:  Neurooncol Pract       Date:  2015-10-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.